Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director departure Appointed director
|
Inmune Bio, Inc. (INMB)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/08/2021 |
4/A
| Xencor Inc (10% Owner) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Acquired 192,533 shares
@ $17.14, valued at
$3.3M
|
|
09/08/2021 |
4/A
| Xencor Inc (10% Owner) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Acquired 192,533 shares
@ $17.14, valued at
$3.3M
|
|
05/20/2019 |
4/A
| Tesi Raymond Joseph (President & CEO) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Bought 11,100 shares
@ $10.75, valued at
$119.3k
|
|
05/20/2019 |
4/A
| Moss David J (CFO, Treasurer & Secretary) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Bought 5,000 shares
@ $10.71, valued at
$53.6k
|
|
05/09/2019 |
4/A
| Tesi Raymond Joseph (President & CEO) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Bought 11,100 shares
@ $9, valued at
$99.9k
|
|
|
|